Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9644)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2015 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gebbing M, Bergmann T, Schulz E, Ehrhardt A. Gene therapeutic approaches to inhibit hepatitis B virus replication. World J Hepatol 2015; 7(2): 150-164 [PMID: 25729471 DOI: 10.4254/wjh.v7.i2.150] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i2/150.htm |
| Number | Citing Articles |
| 1 |
Maggie L. Bobbin, John J. Rossi. RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?. Annual Review of Pharmacology and Toxicology 2016; 56(1): 103 doi: 10.1146/annurev-pharmtox-010715-103633
|
| 2 |
Qianying Chen, Hongzhu Chen, Wenjie Wang, Jiali Liu, Wenyue Liu, Ping Ni, Guowei Sang, Guangji Wang, Fang Zhou, Jingwei Zhang. Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition. European Journal of Pharmaceutical Sciences 2017; 106: 313 doi: 10.1016/j.ejps.2017.06.015
|
| 3 |
Elena Lomonosova, John E. Tavis. Hepatitis B Virus. Methods in Molecular Biology 2017; 1540: 179 doi: 10.1007/978-1-4939-6700-1_14
|
| 4 |
Fuminori Sakurai, Tomohito Tsukamoto, Ryosuke Ono, Fumitaka Nishimae, Aoi Shiota, Shunsuke Iizuka, Kahori Shimizu, Eiko Sakai, Yuji Ishida, Chise Tateno, Kazuaki Chayama, Hiroyuki Mizuguchi. Transduction Properties of an Adenovirus Vector Containing Sequences Complementary to a Liver-Specific microRNA, miR-122a, in the 3′-Untranslated Region of the E4 Gene in Human Hepatocytes from Chimeric Mice with Humanized Liver. Biological and Pharmaceutical Bulletin 2021; 44(10): 1506 doi: 10.1248/bpb.b21-00394
|
| 5 |
Mohube Maepa, Ilke Roelofse, Abdullah Ely, Patrick Arbuthnot. Progress and Prospects of Anti-HBV Gene Therapy Development. International Journal of Molecular Sciences 2015; 16(8): 17589 doi: 10.3390/ijms160817589
|
| 6 |
Ya-Juan Wang, Dong Lu, Yi-Bin Xu, Wei-Qiang Xing, Xian-Kun Tong, Gui-Feng Wang, Chun-Lan Feng, Pei-Lan He, Li Yang, Wei Tang, You-Hong Hu, Jian-Ping Zuo. A Novel Pyridazinone Derivative Inhibits Hepatitis B Virus Replication by Inducing Genome-Free Capsid Formation. Antimicrobial Agents and Chemotherapy 2015; 59(11): 7061 doi: 10.1128/AAC.01558-15
|
| 7 |
Dongdong Zhang, Jiaxi Wang, Donggang Xu. Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. Journal of Controlled Release 2016; 229: 130 doi: 10.1016/j.jconrel.2016.03.020
|
| 8 |
Maria Taskova, Charlotte S. Madsen, Knud J. Jensen, Lykke Haastrup Hansen, Birte Vester, Kira Astakhova. Antisense Oligonucleotides Internally Labeled with Peptides Show Improved Target Recognition and Stability to Enzymatic Degradation. Bioconjugate Chemistry 2017; 28(3): 768 doi: 10.1021/acs.bioconjchem.6b00567
|
| 9 |
Muhammad Arif, Saeed Ahmad, Farman Ali, Ge Fang, Min Li, Dong-Jun Yu. TargetCPP: accurate prediction of cell-penetrating peptides from optimized multi-scale features using gradient boost decision tree. Journal of Computer-Aided Molecular Design 2020; 34(8): 841 doi: 10.1007/s10822-020-00307-z
|
| 10 |
Cheng Peng, Mengji Lu, Dongliang Yang. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV. Virologica Sinica 2015; 30(5): 317 doi: 10.1007/s12250-015-3660-x
|
| 11 |
Elaheh Gholami Parizad, Abbas Ali Imani Fooladi, Hamid Sedighian, Elham Behzadi, Jafar Amani, Afra Khosravi. Immune response induced by recombinant pres2/S-protein and a pres2-S-protein fused with a core 18-27 antigen fragment of hepatitis B virus compared to conventional HBV vaccine. Virus Genes 2023; 59(4): 499 doi: 10.1007/s11262-023-01995-z
|